Aptalis Medical Information
Forest Laboratories
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aptalis Medical Information as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:36 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT01327703 · Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic InsufficiencyForest Laboratories · completed · Exocrine Pancreatic Insufficiency, Cystic Fibrosis · study director
- Ph4NCT01131507 · PR-018: An Open-Label, Safety Extension of Study PR-011Forest Laboratories · completed · Cystic Fibrosis, Exocrine Pancreatic Insufficiency · study director
- Ph4NCT01100606 · A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of AgeForest Laboratories · completed · Cystic Fibrosis, Exocrine Pancreatic Insufficiency · study director
- Ph3NCT01016262 · Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative ProctitisForest Laboratories · terminated · Proctitis, Ulcerative · study director
- Ph3NCT00981214 · Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic InsufficiencyForest Laboratories · completed · Cystic Fibrosis, Exocrine Pancreatic Insufficiency · study director
- Ph3NCT00880100 · Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)Forest Laboratories · completed · Cystic Fibrosis, Pancreatic Insufficiency · study director
- Ph3NCT00788593 · A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)Forest Laboratories · completed · Chronic Pancreatitis, Exocrine Pancreatic Insufficiency · study director
- Ph3NCT00559364 · Safety and Efficacy Study of Viokase® 16 for the Correction of SteatorrheaForest Laboratories · completed · Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Pancreatectomy · study director
- Ph3NCT00513682 · Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)Forest Laboratories · completed · Cystic Fibrosis, Pancreatic Insufficiency · study director
- Ph3NCT00408317 · Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)Forest Laboratories · completed · Cystic Fibrosis, Exocrine Pancreatic Insufficiency · study director
- Ph3NCT00297167 · Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic InsufficiencyForest Laboratories · completed · Cystic Fibrosis, Exocrine Pancreatic Insufficiency · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.